Kevin Kunzmann

Though current use rates have declined since 2017, investigators believe more young adults are transitioning from experimental to habitual use.

The Duke expert reviews key strategies for starting and continuing care with the pivotal glycemic control agent.

Data suggest continued prescribing, not initial prescribing, is linked to opioid addiction risk among exposed family members.

Analysis of patient-reported outcomes last flu season show an approximate 10% increased risk of mild vaccination reactions when receiving both a COVID-19 booster and flu shot instead of a lone booster dose.

An assessment of anti-VEGF dose regimen strategies concludes with little difference in outcomes among treatment arms at 2 years.

The latest EUA, for two-dose NVX-CoV2373, introduces a protein-based adjuvant vaccine to the COVID-19 prevention market.

An Ohio State researcher discusses a new medical center education program for navigating addiction risk in pain patients.

Preventable factors including obesity, hypertension, and physical activity are disparately impacting the rate of dementia among people of color.

Findings from the aV1ation trial highlight the challenges of modern autism clinical research and outcomes of care.

Travis Vandergriff, MD, discusses the unique collaboration with ophthalmologists and urologists in the rare skin condition.

The interventional pulmonology specialist discusses new technology and devices available for diagnosing lung cancer.

An analysis of PSOARING 1 and 2 data show the topical therapy is efficacious across a wide spectrum of psoriatic disease and patient demographics.

An analysis suggests patients on the biologic fared better with adherence and outcomes than those on competitors including adalimumab.

A dive into the manifestation of the rare skin condition, and the impactful role of dermatologists in diagnosing it early.

Investigators did not observe a benefit with the anti-VEGF in preventing intermediate AMD eyes from converting to neovascular disease versus sham.

Field leader Carla Lamb, MD, discusses advances to evaluating and treating chronic diseases including lung cancer and COPD in this latest episode.

New data suggest a combination of cosmetic and psychiatric care for patients with the chronic pigmentation condition may provide multi-systemic benefit.

The issued marketing denial orders require the country's most popular vaping device company remove all commercial products on the basis of insufficient toxicity data.

New phase 3 data show a microencapsulated form of the topical antiseptic and vitamin D derivative is beneficial and tolerable over 12 weeks.

Savanna Perry, PA-C, discussed the challenge of standing out over influencers and estheticians regarding clinical dermatology insight, and the unique offerings of different platforms.

New data from ECZTRA 6 show improved sleep quality, itch relief and quality of life among teenagers treating atopic dermatitis with the IL-13 inhibitor.

Results from a cross-sectional survey suggest consistent patient preferences for treatment outcomes and means of administration.

Savanna Perry, PA-C, founder of The PA Platform, discusses the strategies and goals that go into building an online audience as a healthcare professional.

New phase 3 extension data show the topical PDE-4 inhibitor provided skin clearance to a significant rate of patients with psoriasis.

New research from the UK suggests educational tools for caregivers are in use and beneficial, but none are universally applied.

National prescribing cohort data suggest clinicians buck against the recommended use of the antidepressant.

The decision comes after the company announced positive phase 3 data for the combination vaccine candidate in adults aged 60 years and older.

In a study presented at SLEEP 2022, investigators provide an overview of the impact of obstructive sleep apnea and daytime sleepiness with increased risk of atherosclerotic cardiovascular disease.

A team of investigators observe notably improved health care cost savings among patients who initiated care more than a year prior to those who haven't at all.

Investigators show a novel risk score helped define more than a dozen metabolites associated with the chronic sleep condition.